Skip to main content

Table 1 Literatures review of clinical characteristics of mucinous cystic neoplasm during pregnancy

From: Mucinous cystic neoplasm of the pancreas activated during pregnancy

Author [reference number] Age Maximum diameter of tumor (cm) Diameter of tumor growth during pregnancy (mm) CA19-9 (U/mL) Timing of operation Histological diagnosis ER/PgR Prognosis (years)
Smithers [6] 33 10 NA NA During pregnancy Adenocarcinoma NA NA
Baiocchi [7] 29 NA NA NA After delivery Adenocarcinoma NA Alive (2)
Olsen [8] 25 5 0 NA During pregnancy Benign NA  
Ganepola [9] 37 12 65 NA During pregnancy Benign +/+  
Kato [10] 33 22 + NA During pregnancy Benign +/+  
Matsunaga [11] 28 20 + NA During pregnancy Adenocarcinoma −/+ NA
Fernandez [12] 26 15 NA NA During pregnancy Benign NA  
Herring [13] 34 20 80 NA During pregnancy Adenocarcinoma +/+ Alive (NA)
Ozden [14] 32 15 NA NA After delivery (emergency cesarean) Adenocarcinoma −/− Alive (1)
Ishikawa [15] 33 18 60 NA After delivery Benign −/−  
Ikuta [16] 30 18 NA Normal After delivery (abortion) Benign +/+  
Hakamada [17] 38 14 40 NA During pregnancy Benign NA/+  
Wiseman [18] 32 15 NA NA During pregnancy Benign +/+  
Brown [19] 38 10 NA NA During pregnancy Benign NA  
Shirakawa [20] 34 19 0 Elevated After delivery Benign +/+  
Asciutti [21] 31 8 65 214 After delivery Benign NA  
Nagamura [22] 32 11 NA 4,750 After delivery (emergency cesarean) Adenocarcinoma −/+ Alive (3)
Boyd CA [23] 21 17.2 0 NA During pregnancy Benign NA  
Tsuda [24] 28 14 10 10 During pregnancy Benign +/+  
Present case 33 7.6 16 2,157 After delivery Benign +/+  
  1. CA19-9, cancer antigen 19–9; ER, estrogen receptor; NA, not available; PgR, progesterone receptor.